FENOFIBRATE

FENOFIBRATE was reported 35986 times

These side effects are most commonly reported by patients taking FENOFIBRATE:

# Side effect Count
0 FATIGUE 2211
1 DIARRHOEA 2144
2 NAUSEA 2077
3 DRUG INEFFECTIVE 1834
4 HEADACHE 1589
5 DYSPNOEA 1564
6 OFF LABEL USE 1421
7 DIZZINESS 1409
8 PAIN 1407
9 FALL 1387
10 ASTHENIA 1336
11 ACUTE KIDNEY INJURY 1292
12 VOMITING 1244
13 ARTHRALGIA 1202
14 PRURITUS 1177
15 MALAISE 1080
16 CHRONIC KIDNEY DISEASE 1043
17 WEIGHT DECREASED 971
18 RENAL FAILURE 954
19 COUGH 939
20 DECREASED APPETITE 914
21 DRUG INTERACTION 914
22 MYALGIA 905
23 PYREXIA 894
24 INSOMNIA 888
25 DEATH 863
26 ABDOMINAL PAIN 859
27 PAIN IN EXTREMITY 818
28 RASH 813
29 ABDOMINAL PAIN UPPER 776
30 PNEUMONIA 743
31 CONSTIPATION 703
32 ANXIETY 699
33 BLOOD PRESSURE INCREASED 696
34 BLOOD GLUCOSE INCREASED 690
35 SOMNOLENCE 680
36 BACK PAIN 675
37 CONDITION AGGRAVATED 617
38 DEPRESSION 587
39 WEIGHT INCREASED 575
40 HYPERTENSION 574
41 PRODUCT DOSE OMISSION ISSUE 567
42 URINARY TRACT INFECTION 564
43 MUSCLE SPASMS 555
44 ANAEMIA 554
45 SEPSIS 548
46 GAIT DISTURBANCE 547
47 HYPOTENSION 536
48 FEELING ABNORMAL 518
49 CHEST PAIN 513
50 DEHYDRATION 505
51 CHILLS 471
52 INJECTION SITE PAIN 467
53 FLUSHING 462
54 CONFUSIONAL STATE 454
55 RENAL IMPAIRMENT 449
56 RHABDOMYOLYSIS 434
57 PERIPHERAL SWELLING 433
58 TREMOR 431
59 SYNCOPE 426
60 MYOCARDIAL INFARCTION 423
61 VISION BLURRED 422
62 PANCREATITIS ACUTE 419
63 ABDOMINAL DISCOMFORT 418
64 PANCREATITIS 413
65 NASOPHARYNGITIS 410
66 TACHYCARDIA 400
67 EYE PAIN 391
68 ERYTHEMA 383
69 GASTROINTESTINAL HAEMORRHAGE 380
70 PSORIASIS 376
71 SINUSITIS 373
72 OEDEMA PERIPHERAL 366
73 PRODUCT USE IN UNAPPROVED INDICATION 366
74 BLOOD TRIGLYCERIDES INCREASED 363
75 COVID-19 360
76 DRUG HYPERSENSITIVITY 360
77 ATRIAL FIBRILLATION 350
78 HYPERHIDROSIS 350
79 PARAESTHESIA 349
80 MUSCULAR WEAKNESS 347
81 NEUTROPENIA 347
82 ALOPECIA 342
83 MEMORY IMPAIRMENT 334
84 CEREBROVASCULAR ACCIDENT 333
85 BLOOD CREATININE INCREASED 332
86 GASTROOESOPHAGEAL REFLUX DISEASE 332
87 PULMONARY EMBOLISM 332
88 DRUG DOSE OMISSION 330
89 HAEMATURIA 321
90 COMA 318
91 HYPOAESTHESIA 314
92 TOXICITY TO VARIOUS AGENTS 310
93 DIABETES MELLITUS 304
94 LOSS OF CONSCIOUSNESS 303
95 INCORRECT DOSE ADMINISTERED 302
96 RENAL FAILURE ACUTE 299
97 HAEMOGLOBIN DECREASED 297
98 DYSPEPSIA 291
99 ASCITES 290
100 HAEMATEMESIS 290
101 ABDOMINAL DISTENSION 289
102 HEPATIC FUNCTION ABNORMAL 287
103 TINNITUS 286
104 BLOOD CHOLESTEROL INCREASED 285
105 OROPHARYNGEAL PAIN 283
106 CARDIO-RESPIRATORY ARREST 282
107 WHITE BLOOD CELL COUNT DECREASED 282
108 CONTUSION 279
109 ALTERED STATE OF CONSCIOUSNESS 273
110 BLINDNESS 272
111 PRODUCT USE ISSUE 272
112 BRONCHITIS 269
113 HAEMORRHAGIC STROKE 269
114 INFLUENZA 264
115 BLOOD CREATINE PHOSPHOKINASE INCREASED 262
116 HEAD DISCOMFORT 260
117 DIPLOPIA 257
118 HYPERSENSITIVITY 256
119 PRESYNCOPE 250
120 JOINT SWELLING 249
121 OCULAR DISCOMFORT 248
122 BALANCE DISORDER 247
123 PLATELET COUNT DECREASED 247
124 HOT FLUSH 246
125 GENERALISED OEDEMA 245
126 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 245
127 DRUG INTOLERANCE 244
128 END STAGE RENAL DISEASE 244
129 INFECTION 241
130 ALANINE AMINOTRANSFERASE INCREASED 231
131 ILLNESS 231
132 AMAUROSIS FUGAX 230
133 URTICARIA 230
134 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 230
135 DRY MOUTH 229
136 NEUROPATHY PERIPHERAL 227
137 HYPERTRIGLYCERIDAEMIA 225
138 ARTHRITIS 221
139 CARDIAC FAILURE CONGESTIVE 221
140 ASPARTATE AMINOTRANSFERASE INCREASED 220
141 PALPITATIONS 220
142 HEPATIC ENZYME INCREASED 219
143 GENERAL PHYSICAL HEALTH DETERIORATION 218
144 HYPOKALAEMIA 218
145 HOSPITALISATION 212
146 GASTROINTESTINAL DISORDER 209
147 GLYCOSYLATED HAEMOGLOBIN INCREASED 209
148 HEART RATE INCREASED 209
149 URINARY TRACT DISORDER 207
150 HYPONATRAEMIA 206
151 INTERNATIONAL NORMALISED RATIO INCREASED 206
152 RENAL INJURY 206
153 THROMBOSIS 206
154 PHOTOPHOBIA 205
155 FLATULENCE 204
156 FEELING HOT 202
157 CARDIAC FAILURE 201
158 EMOTIONAL DISTRESS 200
159 PRODUCT QUALITY ISSUE 200
160 OVERDOSE 199
161 HYPOGLYCAEMIA 197
162 DISEASE PROGRESSION 196
163 DRUG-INDUCED LIVER INJURY 194
164 CHEST DISCOMFORT 192
165 DYSPHAGIA 192
166 SEIZURE 192
167 SWELLING 192
168 FEBRILE NEUTROPENIA 188
169 SLEEP DISORDER 187
170 CARDIAC DISORDER 183
171 BLOOD GLUCOSE DECREASED 182
172 COMPLETED SUICIDE 182
173 EPISTAXIS 181
174 VISUAL IMPAIRMENT 180
175 BLOOD PRESSURE DECREASED 179
176 HEPATIC STEATOSIS 179
177 RHINORRHOEA 178
178 MUSCULOSKELETAL STIFFNESS 175
179 THROMBOCYTOPENIA 175
180 NEPHROLITHIASIS 174
181 RENAL DISORDER 174
182 MIGRAINE 173
183 OXYGEN SATURATION DECREASED 173
184 CHOLELITHIASIS 169
185 DRY SKIN 169
186 PLEURAL EFFUSION 169
187 STRESS 169
188 INTENTIONAL PRODUCT MISUSE 168
189 ASTHMA 166
190 CARDIAC ARREST 166
191 CATARACT 166
192 DEEP VEIN THROMBOSIS 166
193 OSTEOARTHRITIS 166
194 HALLUCINATION 165
195 HAEMORRHAGE 164
196 OEDEMA 164
197 LACTIC ACIDOSIS 163
198 DYSGEUSIA 162
199 PRODUCT DOSE OMISSION 161
200 HIGH DENSITY LIPOPROTEIN DECREASED 160
201 NASAL CONGESTION 159
202 NECK PAIN 159
203 RECTAL HAEMORRHAGE 157
204 INFLUENZA LIKE ILLNESS 156
205 VERTIGO 156
206 CELLULITIS 155
207 JAUNDICE 155
208 THERAPY INTERRUPTED 154
209 BLISTER 153
210 BURNING SENSATION 152
211 MUSCULOSKELETAL PAIN 152
212 SEPTIC SHOCK 152
213 DYSPHONIA 151
214 LETHARGY 150
215 LIVER DISORDER 150
216 INTENTIONAL PRODUCT USE ISSUE 149
217 ACUTE MYOCARDIAL INFARCTION 148
218 INJECTION SITE HAEMORRHAGE 148
219 AGITATION 147
220 MOBILITY DECREASED 147
221 RESPIRATORY FAILURE 147
222 INJECTION SITE BRUISING 145
223 POLLAKIURIA 145
224 ANHEDONIA 144
225 HERPES ZOSTER 144
226 NEPHROGENIC ANAEMIA 144
227 SKIN EXFOLIATION 142
228 ANAPHYLACTIC REACTION 141
229 HYPERGLYCAEMIA 141
230 RASH PRURITIC 141
231 SUICIDAL IDEATION 141
232 TUBULOINTERSTITIAL NEPHRITIS 141
233 FLUID RETENTION 140
234 LUNG DISORDER 140
235 CORONARY ARTERY DISEASE 139
236 GAMMA-GLUTAMYLTRANSFERASE INCREASED 139
237 RHEUMATOID ARTHRITIS 138
238 HYPERKALAEMIA 136
239 SWELLING FACE 136
240 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 135
241 DIVERTICULITIS 134
242 NERVOUSNESS 134
243 TYPE 2 DIABETES MELLITUS 134
244 INJECTION SITE ERYTHEMA 132
245 BRADYCARDIA 131
246 MALIGNANT NEOPLASM PROGRESSION 131
247 METABOLIC ACIDOSIS 131
248 UNEVALUABLE EVENT 131
249 AMNESIA 130
250 WHEEZING 130
251 PULMONARY OEDEMA 129
252 PANCYTOPENIA 128
253 DYSPNOEA EXERTIONAL 127
254 SURGERY 127
255 TREATMENT NONCOMPLIANCE 127
256 HAEMATOCHEZIA 126
257 SLEEP APNOEA SYNDROME 125
258 ARTHROPATHY 124
259 BONE PAIN 124
260 UPPER RESPIRATORY TRACT INFECTION 124
261 HEPATIC FAILURE 122
262 OSTEOPOROSIS 121
263 IMPAIRED GASTRIC EMPTYING 120
264 INTESTINAL OBSTRUCTION 119
265 NO ADVERSE EVENT 119
266 DYSURIA 118
267 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 118
268 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 118
269 STOMATITIS 117
270 IRRITABILITY 116
271 THERAPY CESSATION 116
272 HYPOTHYROIDISM 114
273 DIABETES MELLITUS INADEQUATE CONTROL 113
274 DIABETIC KETOACIDOSIS 113
275 HYPERLIPIDAEMIA 113
276 WHITE BLOOD CELL COUNT INCREASED 112
277 C-REACTIVE PROTEIN INCREASED 111
278 PSORIATIC ARTHROPATHY 111
279 RED BLOOD CELL COUNT DECREASED 111
280 INFLAMMATION 110
281 PROTEINURIA 110
282 RASH ERYTHEMATOUS 110
283 THROAT IRRITATION 110
284 UNDERDOSE 110
285 DISORIENTATION 109
286 DRY EYE 109
287 URINARY INCONTINENCE 109
288 ANGINA PECTORIS 108
289 DYSKINESIA 108
290 STAPHYLOCOCCAL INFECTION 108
291 HEAD INJURY 107
292 PRODUCTIVE COUGH 107
293 BLOOD POTASSIUM INCREASED 106
294 DISCOMFORT 105
295 INJECTION SITE PRURITUS 105
296 LIVER FUNCTION TEST ABNORMAL 105
297 DEVICE ISSUE 104
298 HEPATITIS 104
299 LEUKOPENIA 104
300 INFUSION RELATED REACTION 103
301 INJECTION SITE MASS 103
302 COLITIS 102
303 DYSARTHRIA 102
304 LYMPHADENOPATHY 102
305 TRANSIENT ISCHAEMIC ATTACK 101
306 SPEECH DISORDER 100
307 BLOOD POTASSIUM DECREASED 99
308 BLOOD PRESSURE SYSTOLIC INCREASED 99
309 INJURY 99
310 MULTIPLE ORGAN DYSFUNCTION SYNDROME 99
311 MYOPATHY 99
312 ADVERSE DRUG REACTION 98
313 HEART RATE DECREASED 98
314 SKIN LESION 97
315 CHOLESTASIS 96
316 CYSTITIS 96
317 INTERSTITIAL LUNG DISEASE 96
318 INTERVERTEBRAL DISC PROTRUSION 96
319 MENTAL DISORDER 96
320 THERAPEUTIC RESPONSE UNEXPECTED 96
321 DISTURBANCE IN ATTENTION 95
322 INJECTION SITE SWELLING 95
323 LIMB DISCOMFORT 95
324 DYSSTASIA 94
325 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 92
326 BLOOD GLUCOSE ABNORMAL 91
327 CROHN^S DISEASE 91
328 DELIRIUM 91
329 DYSLIPIDAEMIA 91
330 ECZEMA 91
331 HYPOXIA 91
332 HYPOPHAGIA 90
333 PRODUCT SUBSTITUTION ISSUE 89
334 ANGIOEDEMA 88
335 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 88
336 HAEMATOMA 88
337 NIGHTMARE 88
338 ROAD TRAFFIC ACCIDENT 88
339 SKIN BURNING SENSATION 88
340 BLOOD PRESSURE FLUCTUATION 87
341 BLOOD UREA INCREASED 87
342 EYE IRRITATION 87
343 FUNGAL INFECTION 87
344 GASTRITIS 87
345 VIRAL INFECTION 87
346 DEVICE MALFUNCTION 85
347 HEPATIC CYTOLYSIS 85
348 PERICARDIAL EFFUSION 85
349 TRANSAMINASES INCREASED 85
350 DEPRESSED MOOD 84
351 ERECTILE DYSFUNCTION 84
352 LOWER RESPIRATORY TRACT INFECTION 84
353 PHOTOSENSITIVITY REACTION 84
354 ARRHYTHMIA 83
355 DISEASE RECURRENCE 83
356 HAEMORRHOIDS 83
357 SKIN ULCER 83
358 THERAPY NON-RESPONDER 83
359 AGRANULOCYTOSIS 82
360 EYE SWELLING 82
361 GLOMERULAR FILTRATION RATE DECREASED 82
362 MUSCULOSKELETAL CHEST PAIN 82
363 COGNITIVE DISORDER 81
364 HYPOMAGNESAEMIA 81
365 ILL-DEFINED DISORDER 81
366 LYMPHOPENIA 81
367 URINARY RETENTION 81
368 AGEUSIA 80
369 RESPIRATORY TRACT INFECTION 80
370 TASTE DISORDER 79
371 CONVULSION 78
372 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 78
373 EAR INFECTION 78
374 GASTRIC DISORDER 78
375 HEPATOTOXICITY 78
376 MELAENA 78
377 MITRAL VALVE INCOMPETENCE 78
378 UPPER GASTROINTESTINAL HAEMORRHAGE 78
379 AGGRESSION 77
380 HAEMATOCRIT DECREASED 77
381 HIP FRACTURE 77
382 HYPERCHOLESTEROLAEMIA 77
383 LABORATORY TEST ABNORMAL 77
384 NIGHT SWEATS 77
385 SINUS CONGESTION 77
386 SUICIDE ATTEMPT 77
387 ADVERSE EVENT 76
388 HYPERSOMNIA 76
389 INJECTION SITE REACTION 76
390 LIMB INJURY 76
391 NEPHROPATHY 76
392 HAEMOPTYSIS 75
393 LOCALISED INFECTION 75
394 CHROMATURIA 74
395 JOINT STIFFNESS 74
396 PAIN IN JAW 74
397 GAIT INABILITY 73
398 MULTIPLE SCLEROSIS RELAPSE 73
399 ORAL PAIN 73
400 APHASIA 72
401 DRUG EFFECT DECREASED 72
402 ECONOMIC PROBLEM 72
403 GOUT 72
404 OBESITY 72
405 SEASONAL ALLERGY 72
406 THERAPEUTIC RESPONSE DECREASED 72
407 CRYING 71
408 SKIN DISCOLOURATION 71
409 SKIN DISORDER 71
410 HERNIA 70
411 REBOUND ACID HYPERSECRETION 70
412 CLOSTRIDIUM DIFFICILE INFECTION 69
413 HYPERPARATHYROIDISM SECONDARY 69
414 OSTEOPENIA 69
415 HEPATIC CIRRHOSIS 68
416 LACRIMATION INCREASED 68
417 MENTAL STATUS CHANGES 68
418 WITHDRAWAL SYNDROME 68
419 EOSINOPHILIA 67
420 INCREASED APPETITE 67
421 MEDICATION ERROR 67
422 NEUTROPHIL COUNT DECREASED 67
423 PRODUCT DOSE OMISSION IN ERROR 67
424 TREATMENT FAILURE 67
425 ABDOMINAL PAIN LOWER 66
426 ACUTE RESPIRATORY FAILURE 66
427 BLOOD PRESSURE ABNORMAL 66
428 DRUG WITHDRAWAL SYNDROME 66
429 ERUCTATION 66
430 FEELING COLD 66
431 FREQUENT BOWEL MOVEMENTS 66
432 GASTROENTERITIS VIRAL 66
433 LIVER INJURY 66
434 NEURALGIA 66
435 OCULAR HYPERAEMIA 66
436 BLOOD ALKALINE PHOSPHATASE INCREASED 65
437 EXPOSURE DURING PREGNANCY 65
438 FAECES DISCOLOURED 65
439 INJECTION SITE EXTRAVASATION 65
440 MATERNAL EXPOSURE DURING PREGNANCY 65
441 MULTIPLE SCLEROSIS 65
442 PANIC ATTACK 65
443 PRURITUS GENERALISED 65
444 SINUS DISORDER 65
445 THIRST 65
446 INTENTIONAL DOSE OMISSION 64
447 MOVEMENT DISORDER 64
448 PROCEDURAL PAIN 64
449 HYPOACUSIS 63
450 MULTIPLE FRACTURES 63
451 PALLOR 63
452 SPLENOMEGALY 63
453 CORONARY ARTERY OCCLUSION 62
454 HEPATOCELLULAR INJURY 62
455 MUCOSAL INFLAMMATION 62
456 MUSCLE ATROPHY 62
457 PULMONARY MASS 62
458 RASH MACULO-PAPULAR 62
459 RETCHING 62
460 SEROTONIN SYNDROME 62
461 ACCIDENTAL EXPOSURE TO PRODUCT 61
462 NEOPLASM MALIGNANT 61
463 RIB FRACTURE 61
464 ABNORMAL DREAMS 60
465 ACUTE RESPIRATORY DISTRESS SYNDROME 60
466 BLOOD MAGNESIUM DECREASED 60
467 CARDIOMYOPATHY 60
468 LOW DENSITY LIPOPROTEIN INCREASED 60
469 MIDDLE INSOMNIA 60
470 ORTHOSTATIC HYPOTENSION 60
471 UPPER LIMB FRACTURE 60
472 WRONG TECHNIQUE IN DRUG USAGE PROCESS 60
473 BONE DENSITY DECREASED 59
474 EJECTION FRACTION DECREASED 59
475 LEUKOCYTOSIS 59
476 SWOLLEN TONGUE 59
477 ABNORMAL BEHAVIOUR 58
478 ACUTE MYELOID LEUKAEMIA 58
479 ANGER 58
480 BLOOD PRESSURE DIASTOLIC DECREASED 58
481 DERMATITIS ATOPIC 58
482 DRUG EFFECT INCOMPLETE 58
483 DRUG LEVEL INCREASED 58
484 ELECTROCARDIOGRAM QT PROLONGED 58
485 ENCEPHALOPATHY 58
486 RESTLESSNESS 58
487 THYROID DISORDER 58
488 BACK DISORDER 57
489 BASAL CELL CARCINOMA 57
490 CARPAL TUNNEL SYNDROME 57
491 DEMENTIA 57
492 FEEDING DISORDER 57
493 FOOT FRACTURE 57
494 IMPAIRED HEALING 57
495 LIP SWELLING 57
496 NEEDLE ISSUE 57
497 PNEUMONITIS 57
498 PRODUCT ODOUR ABNORMAL 57
499 SKIN LACERATION 57
500 VITAMIN D DECREASED 57
501 COAGULOPATHY 56
502 HEPATOMEGALY 56
503 POOR QUALITY SLEEP 56
504 PRODUCT STORAGE ERROR 56
505 RASH MACULAR 56
506 CEREBRAL HAEMORRHAGE 55
507 FIBROMYALGIA 55
508 RASH PAPULAR 55
509 RENAL TUBULAR NECROSIS 55
510 CHOLECYSTITIS 54
511 DRUG ERUPTION 54
512 LEFT VENTRICULAR DYSFUNCTION 54
513 MUSCULOSKELETAL DISCOMFORT 54
514 BLOOD IRON DECREASED 53
515 CONTRAINDICATED PRODUCT ADMINISTERED 53
516 DEAFNESS 53
517 DEPRESSED LEVEL OF CONSCIOUSNESS 53
518 EYE DISORDER 53
519 EYE PRURITUS 53
520 JOINT INJURY 53
521 KIDNEY INFECTION 53
522 DIALYSIS 52
523 KNEE ARTHROPLASTY 52
524 LUNG NEOPLASM MALIGNANT 52
525 RESTLESS LEGS SYNDROME 52
526 BLOOD SODIUM DECREASED 51
527 EUGLYCAEMIC DIABETIC KETOACIDOSIS 51
528 FOETAL EXPOSURE DURING PREGNANCY 51
529 MOOD ALTERED 51
530 ORAL HERPES 51
531 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51
532 PROSTATE CANCER 51
533 RESPIRATORY TRACT CONGESTION 51
534 ROTATOR CUFF SYNDROME 51
535 VISUAL ACUITY REDUCED 51
536 ACNE 50
537 BACK INJURY 50
538 EAR PAIN 50
539 HAIR COLOUR CHANGES 50
540 HEART RATE IRREGULAR 50
541 HYPERCALCAEMIA 50
542 LOWER LIMB FRACTURE 50
543 NEPHROPATHY TOXIC 50
544 PRODUCT PHYSICAL ISSUE 50
545 THERAPEUTIC PRODUCT EFFECT DECREASED 50
546 COLITIS ULCERATIVE 49
547 DELUSION 49
548 DRUG ADMINISTRATION ERROR 49
549 DRUG DEPENDENCE 49
550 EATING DISORDER 49
551 FEELING JITTERY 49
552 INTERVERTEBRAL DISC DEGENERATION 49
553 RESPIRATORY DISORDER 49
554 RESPIRATORY DISTRESS 49
555 SPINAL FRACTURE 49
556 UPPER-AIRWAY COUGH SYNDROME 49
557 VITAMIN D DEFICIENCY 49
558 APHTHOUS ULCER 48
559 BONE MARROW FAILURE 48
560 BRAIN FOG 48
561 EMOTIONAL DISORDER 48
562 HIATUS HERNIA 48
563 HYPOKINESIA 48
564 INTENTIONAL OVERDOSE 48
565 ISCHAEMIC STROKE 48
566 TENDON RUPTURE 48
567 BLOOD BILIRUBIN INCREASED 47
568 BODY HEIGHT DECREASED 47
569 CARDIOGENIC SHOCK 47
570 DERMATITIS 47
571 EPILEPSY 47
572 GASTROENTERITIS 47
573 PANCREATITIS NECROTISING 47
574 RALES 47
575 SKIN CANCER 47
576 TOOTH INFECTION 47
577 BLOOD CHOLESTEROL ABNORMAL 46
578 BLOOD COUNT ABNORMAL 46
579 BLOOD LACTATE DEHYDROGENASE INCREASED 46
580 BLOOD URINE PRESENT 46
581 CONJUNCTIVITIS 46
582 DIABETIC NEUROPATHY 46
583 FULL BLOOD COUNT DECREASED 46
584 MYOSITIS 46
585 NERVE COMPRESSION 46
586 RENAL CYST 46
587 SHOCK HAEMORRHAGIC 46
588 ACCIDENTAL OVERDOSE 45
589 ACUTE CORONARY SYNDROME 45
590 ANKLE FRACTURE 45
591 GASTRIC ULCER 45
592 INJECTION SITE NODULE 45
593 LIPASE INCREASED 45
594 MENTAL IMPAIRMENT 45
595 MUSCLE TWITCHING 45
596 NERVOUS SYSTEM DISORDER 45
597 OSTEOMYELITIS 45
598 PNEUMONIA ASPIRATION 45
599 RED BLOOD CELL SEDIMENTATION RATE INCREASED 45
600 SNEEZING 45
601 VENTRICULAR TACHYCARDIA 45
602 CANDIDA INFECTION 44
603 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 44
604 DEVICE LEAKAGE 44
605 INCONTINENCE 44
606 IRRITABLE BOWEL SYNDROME 44
607 LEFT VENTRICULAR HYPERTROPHY 44
608 POST PROCEDURAL COMPLICATION 44
609 PRODUCT ADHESION ISSUE 44
610 PROSTATIC SPECIFIC ANTIGEN INCREASED 44
611 SCIATICA 44
612 THINKING ABNORMAL 44
613 TOXIC SKIN ERUPTION 44
614 WOUND 44
615 GALLBLADDER DISORDER 43
616 INSURANCE ISSUE 43
617 NEUROLEPTIC MALIGNANT SYNDROME 43
618 PLASMA CELL MYELOMA 43
619 PRESCRIBED OVERDOSE 43
620 TRICUSPID VALVE INCOMPETENCE 43
621 UNRESPONSIVE TO STIMULI 43
622 CARDIOMEGALY 42
623 CAROTID ARTERY STENOSIS 42
624 EYE INFECTION 42
625 FEAR 42
626 FLANK PAIN 42
627 INFUSION SITE PAIN 42
628 JOINT DISLOCATION 42
629 MYELODYSPLASTIC SYNDROME 42
630 PULMONARY HYPERTENSION 42
631 SKIN FISSURES 42
632 SPINAL OSTEOARTHRITIS 42
633 SUBDURAL HAEMATOMA 42
634 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 42
635 ARTERIOSCLEROSIS 41
636 BREAST CANCER 41
637 ELECTROCARDIOGRAM ABNORMAL 41
638 EXPIRED PRODUCT ADMINISTERED 41
639 FACE OEDEMA 41
640 FEMUR FRACTURE 41
641 GLAUCOMA 41
642 HALLUCINATION, VISUAL 41
643 MALNUTRITION 41
644 MOOD SWINGS 41
645 PARKINSON^S DISEASE 41
646 RASH GENERALISED 41
647 SCAR 41
648 ACIDOSIS 40
649 BLOOD TESTOSTERONE DECREASED 40
650 BODY TEMPERATURE INCREASED 40
651 FOOT DEFORMITY 40
652 ILEUS 40
653 INITIAL INSOMNIA 40
654 METASTASES TO LIVER 40
655 MOUTH ULCERATION 40
656 MULTIPLE ALLERGIES 40
657 MUSCLE TIGHTNESS 40
658 MYOCLONUS 40
659 PANCREATIC CARCINOMA 40
660 PREMATURE BABY 40
661 SMALL INTESTINAL OBSTRUCTION 40
662 SUPRAVENTRICULAR TACHYCARDIA 40
663 ABSCESS 39
664 ACTIVITIES OF DAILY LIVING IMPAIRED 39
665 ATELECTASIS 39
666 LIVER FUNCTION TEST INCREASED 39
667 PRODUCT TASTE ABNORMAL 39
668 SHOCK 39
669 ARTERIOSCLEROSIS CORONARY ARTERY 38
670 BACTERIAL INFECTION 38
671 BLOOD GLUCOSE FLUCTUATION 38
672 CHOLECYSTECTOMY 38
673 CHRONIC SINUSITIS 38
674 HALLUCINATION, AUDITORY 38
675 MALIGNANT MELANOMA 38
676 MASS 38
677 MUSCULOSKELETAL DISORDER 38
678 MYOCARDITIS 38
679 PARANASAL SINUS DISCOMFORT 38
680 PARANOIA 38
681 SEDATION 38
682 TARDIVE DYSKINESIA 38
683 URINE OUTPUT DECREASED 38
684 ABNORMAL LOSS OF WEIGHT 37
685 ATRIOVENTRICULAR BLOCK 37
686 COVID-19 PNEUMONIA 37
687 CYST 37
688 DERMATITIS CONTACT 37
689 DIABETIC METABOLIC DECOMPENSATION 37
690 GLUCOSE TOLERANCE IMPAIRED 37
691 INCORRECT DRUG ADMINISTRATION DURATION 37
692 INTERNAL HAEMORRHAGE 37
693 NODULE 37
694 PRODUCT ADMINISTRATION ERROR 37
695 QUALITY OF LIFE DECREASED 37
696 RENAL FAILURE CHRONIC 37
697 TOOTHACHE 37
698 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 36
699 DIZZINESS POSTURAL 36
700 EXOSTOSIS 36
701 EXTRA DOSE ADMINISTERED 36
702 HEPATIC FIBROSIS 36
703 HYPOCALCAEMIA 36
704 LARGE INTESTINE POLYP 36
705 NASAL DISCOMFORT 36
706 NOCTURIA 36
707 ODYNOPHAGIA 36
708 PETECHIAE 36
709 PRE-EXISTING CONDITION IMPROVED 36
710 PRODUCT ADMINISTRATION INTERRUPTED 36
711 PRODUCT AVAILABILITY ISSUE 36
712 PULMONARY FIBROSIS 36
713 PULMONARY THROMBOSIS 36
714 SKIN IRRITATION 36
715 SPINAL OPERATION 36
716 TOOTH DISORDER 36
717 ANAL INCONTINENCE 35
718 AORTIC ARTERIOSCLEROSIS 35
719 BUNDLE BRANCH BLOCK LEFT 35
720 CHOKING 35
721 DEVICE DIFFICULT TO USE 35
722 DISSEMINATED INTRAVASCULAR COAGULATION 35
723 DRUG PRESCRIBING ERROR 35
724 HOSPICE CARE 35
725 HYPERTONIC BLADDER 35
726 HYPOVOLAEMIC SHOCK 35
727 JOINT RANGE OF MOTION DECREASED 35
728 LIGAMENT SPRAIN 35
729 LYMPHOCYTE COUNT DECREASED 35
730 NEOPLASM PROGRESSION 35
731 NEUROTOXICITY 35
732 PREMATURE DELIVERY 35
733 PRESCRIBED UNDERDOSE 35
734 PULMONARY TOXICITY 35
735 THERAPEUTIC RESPONSE SHORTENED 35
736 WEIGHT FLUCTUATION 35
737 ACCIDENTAL EXPOSURE 34
738 BLOOD CREATININE ABNORMAL 34
739 ESCHERICHIA URINARY TRACT INFECTION 34
740 EXTRAPYRAMIDAL DISORDER 34
741 HAIR TEXTURE ABNORMAL 34
742 HIP ARTHROPLASTY 34
743 IMPAIRED QUALITY OF LIFE 34
744 INCREASED TENDENCY TO BRUISE 34
745 LOCAL SWELLING 34
746 MULTI-ORGAN FAILURE 34
747 NASAL DRYNESS 34
748 NERVE INJURY 34
749 NEUTROPHIL COUNT INCREASED 34
750 ORTHOPNOEA 34
751 PRODUCT PRESCRIBING ISSUE 34
752 RHINITIS 34
753 STENOSIS 34
754 STENT PLACEMENT 34
755 TACHYPNOEA 34
756 VULVOVAGINAL PRURITUS 34
757 WRIST FRACTURE 34
758 ABASIA 33
759 ANAPHYLACTIC SHOCK 33
760 CARDIOVASCULAR DISORDER 33
761 FAECES SOFT 33
762 HAEMORRHAGIC ANAEMIA 33
763 HYPOPHOSPHATAEMIA 33
764 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 33
765 LOWER GASTROINTESTINAL HAEMORRHAGE 33
766 MYELOSUPPRESSION 33
767 PHARYNGEAL SWELLING 33
768 PHARYNGITIS 33
769 RENAL PAIN 33
770 SCHIZOPHRENIA 33
771 THERAPY PARTIAL RESPONDER 33
772 THROAT TIGHTNESS 33
773 VENTRICULAR EXTRASYSTOLES 33
774 ADRENAL INSUFFICIENCY 32
775 BEDRIDDEN 32
776 BLOOD CALCIUM INCREASED 32
777 BLOOD TRIGLYCERIDES ABNORMAL 32
778 DIARRHOEA HAEMORRHAGIC 32
779 EYE HAEMORRHAGE 32
780 FOURNIER^S GANGRENE 32
781 GENERALISED TONIC-CLONIC SEIZURE 32
782 HAEMOGLOBIN ABNORMAL 32
783 HYPERBILIRUBINAEMIA 32
784 PANCREATITIS CHRONIC 32
785 PANCREATITIS HAEMORRHAGIC 32
786 PNEUMOTHORAX 32
787 POISONING DELIBERATE 32
788 RENAL FUNCTION TEST ABNORMAL 32
789 RHINALGIA 32
790 SYNOVIAL CYST 32
791 TOOTH ABSCESS 32
792 ULCER 32
793 AORTIC VALVE INCOMPETENCE 31
794 BLADDER CANCER 31
795 CEREBRAL INFARCTION 31
796 DECREASED ACTIVITY 31
797 DRUG ABUSE 31
798 DYSTONIA 31
799 GASTROINTESTINAL PAIN 31
800 IRON DEFICIENCY ANAEMIA 31
801 OESOPHAGITIS 31
802 POLYP 31
803 SKIN HAEMORRHAGE 31
804 TENDONITIS 31
805 TROPONIN INCREASED 31
806 VENTRICULAR ARRHYTHMIA 31
807 ANOREXIA 30
808 ANURIA 30
809 APHONIA 30
810 ATRIAL FLUTTER 30
811 BLINDNESS UNILATERAL 30
812 BLOOD PRESSURE DIASTOLIC ABNORMAL 30
813 BLOOD THYROID STIMULATING HORMONE INCREASED 30
814 COLD SWEAT 30
815 CYANOSIS 30
816 DILATATION VENTRICULAR 30
817 DIVERTICULUM 30
818 DRUG DOSE OMISSION BY DEVICE 30
819 GROIN PAIN 30
820 GYNAECOMASTIA 30
821 HEPATITIS ACUTE 30
822 LYMPHOEDEMA 30
823 MANIA 30
824 MENISCUS INJURY 30
825 PHARYNGEAL OEDEMA 30
826 TOXIC EPIDERMAL NECROLYSIS 30
827 WHITE BLOOD CELL COUNT ABNORMAL 30
828 ATAXIA 29
829 BOWEL MOVEMENT IRREGULARITY 29
830 COLON CANCER 29
831 CORONARY ARTERY STENOSIS 29
832 DERMATITIS EXFOLIATIVE 29
833 DRUG LEVEL DECREASED 29
834 DRUG RESISTANCE 29
835 EYELID OEDEMA 29
836 GLOSSODYNIA 29
837 HAEMODIALYSIS 29
838 HYPERNATRAEMIA 29
839 HYPOVOLAEMIA 29
840 IMMUNE SYSTEM DISORDER 29
841 IMMUNODEFICIENCY 29
842 METABOLIC SYNDROME 29
843 MITRAL VALVE DISEASE 29
844 PANCREATIC DISORDER 29
845 PELVIC PAIN 29
846 PURPURA 29
847 SUSPECTED SUICIDE 29
848 VAGINAL HAEMORRHAGE 29
849 VULVOVAGINAL BURNING SENSATION 29
850 APPLICATION SITE ERYTHEMA 28
851 BLOOD TEST ABNORMAL 28
852 DIASTOLIC DYSFUNCTION 28
853 FAECALOMA 28
854 HEPATIC NECROSIS 28
855 HEPATITIS CHOLESTATIC 28
856 HYPERKERATOSIS 28
857 IMPAIRED WORK ABILITY 28
858 INCORRECT DOSE ADMINISTERED BY DEVICE 28
859 INTESTINAL PERFORATION 28
860 LARYNGITIS 28
861 MOTOR DYSFUNCTION 28
862 ORAL CANDIDIASIS 28
863 PERITONITIS 28
864 PROSTATOMEGALY 28
865 PSYCHOTIC DISORDER 28
866 PULMONARY CONGESTION 28
867 RENAL CANCER 28
868 SCRATCH 28
869 SINUS TACHYCARDIA 28
870 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 28
871 ULCER HAEMORRHAGE 28
872 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 27
873 APPLICATION SITE PAIN 27
874 BIPOLAR DISORDER 27
875 BLOOD CALCIUM DECREASED 27
876 BODY TEMPERATURE DECREASED 27
877 CARDIAC OPERATION 27
878 CLOSTRIDIUM DIFFICILE COLITIS 27
879 DUODENITIS 27
880 FRACTURE 27
881 FULL BLOOD COUNT ABNORMAL 27
882 FURUNCLE 27
883 HEMIPARESIS 27
884 HYPERTENSIVE CRISIS 27
885 INJECTION SITE URTICARIA 27
886 MADAROSIS 27
887 MICTURITION URGENCY 27
888 MONOCYTE COUNT INCREASED 27
889 MYOCARDIAL ISCHAEMIA 27
890 OSTEONECROSIS 27
891 PANCREATITIS RELAPSING 27
892 PSYCHOLOGICAL TRAUMA 27
893 RESPIRATORY ARREST 27
894 SKIN WEEPING 27
895 AFFECT LABILITY 26
896 BONE DISORDER 26
897 BURSITIS 26
898 CHOLESTATIC LIVER INJURY 26
899 CYTOLYTIC HEPATITIS 26
900 DEVICE RELATED INFECTION 26
901 EMPHYSEMA 26
902 ESSENTIAL HYPERTENSION 26
903 GASTRIC ULCER HAEMORRHAGE 26
904 GINGIVAL BLEEDING 26
905 HAEMORRHAGE INTRACRANIAL 26
906 HEPATIC ENCEPHALOPATHY 26
907 HUNGER 26
908 INCORRECT PRODUCT ADMINISTRATION DURATION 26
909 METASTASES TO BONE 26
910 MYOGLOBIN BLOOD INCREASED 26
911 NEUTROPHIL COUNT ABNORMAL 26
912 OCULAR ICTERUS 26
913 PARALYSIS 26
914 PERICARDITIS 26
915 PERIPHERAL SENSORY NEUROPATHY 26
916 PRODUCT PRESCRIBING ERROR 26
917 SARS-COV-2 TEST POSITIVE 26
918 SLUGGISHNESS 26
919 SQUAMOUS CELL CARCINOMA 26
920 ANGINA UNSTABLE 25
921 BLOOD LOSS ANAEMIA 25
922 BLOOD PRESSURE SYSTOLIC ABNORMAL 25
923 CARDIAC PACEMAKER INSERTION 25
924 DISTRIBUTIVE SHOCK 25
925 ECCHYMOSIS 25
926 ESCHERICHIA INFECTION 25
927 GASTROINTESTINAL INFECTION 25
928 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 25
929 HAIR DISORDER 25
930 KETOACIDOSIS 25
931 LACERATION 25
932 MACULAR DEGENERATION 25
933 MUCOSAL DRYNESS 25
934 MUSCLE FATIGUE 25
935 NEOPLASM 25
936 NEPHROTIC SYNDROME 25
937 NORMOCHROMIC NORMOCYTIC ANAEMIA 25
938 ORAL DISCOMFORT 25
939 OSTEONECROSIS OF JAW 25
940 PAPULE 25
941 PLATELET COUNT ABNORMAL 25
942 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25
943 PROTHROMBIN TIME PROLONGED 25
944 PULMONARY ARTERIAL HYPERTENSION 25
945 SENSORY DISTURBANCE 25
946 SKIN PLAQUE 25
947 SPINAL PAIN 25
948 TENDERNESS 25
949 WALKING AID USER 25
950 ALANINE AMINOTRANSFERASE ABNORMAL 24
951 ANGIOPATHY 24
952 ARTERIAL OCCLUSIVE DISEASE 24
953 BENIGN PROSTATIC HYPERPLASIA 24
954 BRONCHOSPASM 24
955 CARDIAC FLUTTER 24
956 CYTOKINE RELEASE SYNDROME 24
957 DERMATITIS ALLERGIC 24
958 FLUID OVERLOAD 24
959 GLOMERULAR FILTRATION RATE INCREASED 24
960 HAEMOLYSIS 24
961 HYPERTHYROIDISM 24
962 INCORRECT ROUTE OF DRUG ADMINISTRATION 24
963 KIDNEY FIBROSIS 24
964 KNEE OPERATION 24
965 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 24
966 LICHENOID KERATOSIS 24
967 METABOLIC ENCEPHALOPATHY 24
968 PARAESTHESIA ORAL 24
969 PLATELET COUNT INCREASED 24
970 POLYNEUROPATHY 24
971 PRODUCT DISPENSING ERROR 24
972 PYELONEPHRITIS 24
973 STEVENS-JOHNSON SYNDROME 24
974 SYSTEMIC LUPUS ERYTHEMATOSUS 24
975 UROSEPSIS 24
976 ABDOMINAL TENDERNESS 23
977 ABORTION SPONTANEOUS 23
978 ASPIRATION 23
979 BLOOD BILIRUBIN ABNORMAL 23
980 CARDIAC MURMUR 23
981 CHOLANGITIS 23
982 COORDINATION ABNORMAL 23
983 DYSGRAPHIA 23
984 ELECTROLYTE IMBALANCE 23
985 EOSINOPHIL COUNT INCREASED 23
986 ERYTHEMA MULTIFORME 23
987 EXPOSURE VIA SKIN CONTACT 23
988 FORMICATION 23
989 HAND FRACTURE 23
990 HEREDITARY ANGIOEDEMA 23
991 IMPAIRED DRIVING ABILITY 23
992 INJECTION SITE RASH 23
993 JAUNDICE CHOLESTATIC 23
994 PANCREATIC CARCINOMA METASTATIC 23
995 POTENTIATING DRUG INTERACTION 23
996 SCAB 23
997 SENSORY LOSS 23
998 SKIN INFECTION 23
999 SUDDEN DEATH 23